Calunsag, Lovely Arfe C.
HRN: 25-88-59 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/17/2024
METRONIDAZOLE 500MG (TAB)
09/17/2024
09/24/2024
PO
500mg
TID X 7 Days
S/P NSVD With Thickly MSAF
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes